HPS2-THRIVE trial: Side-effects cause a quarter of heart patients to stop treatment
- Details
- Category: Research
The largest randomised study of the vitamin niacin in patients with occlusive arterial disease (narrowing of the arteries) has shown a significant increase in adverse side-effects when it is combined with statin treatment. Results from the HPS2-THRIVE study (Heart Protection Study 2 - Treatment of HDL to Reduce the Incidence of Vascular Events), including the reasons patients stopped the study treatment, are published online in the European Heart Journal.
Chemists find help from nature in fighting cancer
- Details
- Category: Research
Inspired by a chemical that fungi secrete to defend their territory, MIT chemists have synthesized and tested several dozen compounds that may hold promise as potential cancer drugs. A few years ago, MIT researchers led by associate professor of chemistry Mohammad Movassaghi became the first to chemically synthesize 11,11'-dideoxyverticillin, a highly complex fungal compound that has shown anti-cancer activity in previous studies.
New cancer 'vaccine' shows future promise in treating and preventing metastatic cancers
- Details
- Category: Research
Preclinical, laboratory studies suggest a novel immunotherapy could potentially work like a vaccine against metastatic cancers, according to scientists at Virginia Commonwealth University Massey Cancer Center. Results from a recent study show the therapy could treat metastatic cancers and be used in combination with current cancer therapies while helping to prevent the development of new metastatic tumors and train specialized immune system cells to guard against cancer relapse.
Virus shows promise as prostate cancer treatment
- Details
- Category: Research
A recombinant Newcastle disease virus kills all kinds of prostate cancer cells, including hormone resistant cells, but leaves normal cells unscathed, according to a paper published online ahead of print in the Journal of Virology. A treatment for prostate cancer based on this virus would avoid the adverse side effects typically associated with hormonal treatment for prostate cancer,
Cortisone can increase risk of acute pancreatitis
- Details
- Category: Research
A new study from Karolinska Institutet in Sweden shows that cortisone - a hormone used in certain medicines - increases the risk of acute pancreatitis. The results are published in the scientific journal JAMA Internal Medicine. According to the researchers, they suggest that patients treated with cortisone in some forms should be informed of the risks and advised to refrain from alcohol and smoking.
Scientists unveil secrets of important natural antibiotic
- Details
- Category: Research
An international team of scientists has discovered how an important natural antibiotic called dermcidin, produced by our skin when we sweat, is a highly efficient tool to fight tuberculosis germs and other dangerous bugs. Their results could contribute to the development of new antibiotics that control multi-resistant bacteria.
Mushroom-supplemented soybean extract shows therapeutic promise for advanced prostate cancer
- Details
- Category: Research
A natural, nontoxic product called genistein-combined polysaccharide, or GCP, which is commercially available in health stores, could help lengthen the life expectancy of certain prostate cancer patients, UC Davis researchers have found. Men with prostate cancer that has spread to other parts of the body, known as metastatic cancer, and who have had their testosterone lowered with drug therapy are most likely to benefit.
More Pharma News ...
- New study on Hepatitis C drug treatment in vivo and in vitro
- Patient-specific cancer cell lines designed to predict chemotherapy sensitivity
- Frequently prescribed drug used in concerning ways with harmful side effects
- Vitamin C is beneficial against the common cold
- Diclofenac used and recommended globally, despite cardiovascular risks
- International study suggests improved treatment alternative for lymphoid leukemia
- Compound stimulates tumor-fighting protein in cancer therapy